Immunotherapy News and Research RSS Feed - Immunotherapy News and Research

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.
New study reveals CAR T cells can function as micro-pharmacies for precise therapeutic delivery

New study reveals CAR T cells can function as micro-pharmacies for precise therapeutic delivery

There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells. [More]
Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal's brain — and a way to block that protein's action. [More]
Recycling existing drugs may help fight several types of cancer

Recycling existing drugs may help fight several types of cancer

Researchers at the University of Bergen have discovered that a drug against kidney cancer possibly can fight several types of cancer. [More]
T-Bear brings hope to kids diagnosed with cancer at Seattle Children's Hospital

T-Bear brings hope to kids diagnosed with cancer at Seattle Children's Hospital

He may not be able to fly, or be as fast as the speed of light, but for children who have been diagnosed with cancer at Seattle Children's, the cuddly teddy bear who wears a mask and purple cape is still a super hero to them - he gives them strength. [More]
Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Single high-intensity SBRT dose can be effective in treating early stage NSCLC patients

Stereotactic body radiation therapy (SBRT) is a specialized and highly targeted method of delivering radiotherapy, or radiation therapy, to treat cancer. [More]
Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments. [More]
Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease. [More]
Ludwig researchers shed more light on key requirement for function of regulatory T cells

Ludwig researchers shed more light on key requirement for function of regulatory T cells

A Ludwig Cancer Research study published online September 5th in Nature Immunology illuminates a key requirement for the function of regulatory T cells—immune cells that play a critical role in many biological processes, from suppressing inflammation and deadly autoimmunity to helping tumors evade immune attack. [More]
MSK introduces unique program to expand, streamline patient access to high-quality cancer care

MSK introduces unique program to expand, streamline patient access to high-quality cancer care

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with the institution for initial or ongoing cancer care. [More]
Novel immunotherapy shows promise against AML in clinical trial

Novel immunotherapy shows promise against AML in clinical trial

A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place. [More]
Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management. [More]
Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

Sanford wins $11.7 million NIH grant to translate laboratory cancer research into clinical trials

The Cancer Biology Research Center at Sanford Research is the recipient of a five-year, nearly $11.7 million grant from the National Institutes of Health to translate laboratory research into clinical trials for head and neck and pediatric cancers. [More]
Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. [More]
Novel therapy offers hope for effective treatment of intractable metastatic cancers

Novel therapy offers hope for effective treatment of intractable metastatic cancers

Cancer treatments that mobilize the body's immune system to fight the disease have generated a lot of excitement in the past few years. [More]
Pathologists to collaborate on promise, challenges of immunotherapy at CAP16

Pathologists to collaborate on promise, challenges of immunotherapy at CAP16

At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25. [More]
Allergists show kids can be near food allergy triggers without fear

Allergists show kids can be near food allergy triggers without fear

Allergists realize people who are severely allergic to a food can experience great anxiety when encountering the food in any form. [More]
Research findings may pave way for innovative treatments of multiple sclerosis

Research findings may pave way for innovative treatments of multiple sclerosis

Researchers at the Research Center for Immunotherapy and the Focus Program Translational Neurosciences of Johannes Gutenberg University Mainz have identified a new mechanism that is involved in the development of autoimmune diseases. [More]
Chronic cough different than cough from cold, says allergist

Chronic cough different than cough from cold, says allergist

There's been a lot of talk about politicians and coughs lately. And we've all seen public figures struggle with it. [More]
UNSW set to become home to world’s first pre-production prototype of high resolution microscope

UNSW set to become home to world’s first pre-production prototype of high resolution microscope

Cancer researchers in NSW will now have access to a range of cutting edge technology, including a world-first super-resolution microscope at UNSW, thanks a $4 million investment by the Cancer Institute NSW. [More]
Research reveals how Zika virus arrests fetal brain development in pigtail macaque

Research reveals how Zika virus arrests fetal brain development in pigtail macaque

For the first time, abnormal brain development following a Zika infection during pregnancy has been documented experimentally in the offspring of a non-human primate. [More]
Advertisement
Advertisement